Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

QEEG-NEUROFEEDBACK FOR COGNITIVE REHABILITATION IN LONG COVID-19 SURVIVORS WITH BRAIN FOG: A Sham-controlled, Double-blind, Randomized Controlled Trial

NCT07005921 is registered in ClinicalTrials.gov with Jade Carvalho Da Silva as lead sponsor.

NCT NCT07005921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07005921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
QEEG-NEUROFEEDBACK FOR COGNITIVE REHABILITATION IN LONG COVID-19 SURVIVORS WITH BRAIN FOG: A Sham-controlled, Double-blind, Randomized Controlled Trial
Lead sponsor
Jade Carvalho Da Silva
Phase
Not applicable
Overall status
Completed
Start date
June 10, 2025
Completion date
August 14, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain fog, long covid, post-acute covid-19 syndrome